McKesson Takes Minority Stake as CD&R Leads $5.8 Billion Buyout of Option Care Health
Shareholders will receive $32.05 per share, a 37% premium, as CD&R and McKesson take Option Care Health private.
/ 4 items
#MCK↓
McKesson and CD&R close in on buyout of US infusion provider
Option Care Health is in advanced talks on a joint bid from McKesson and CD&R valuing it at more than $5 billion, including debt.
McKesson and Cardinal Health Extend CVS Drug Supply Deals Through 2032
BofA kept Buy ratings, calling the news a clearing event.
McKesson Buys Maryland CRO Precision Medicine Group in $2.25 Billion Deal
Morgan Stanley calls McKesson’s $2.25B Precision Medicine buy a logical CRO addition unlocking a $25B oncology market.